Original language | English |
---|---|
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 28 |
Publication status | Published - Sep 2017 |
Externally published | Yes |
Event | 42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sep 2017 → 12 Sep 2017 |
Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26
S. Karim, K. Ding, P. Bradbury, P. Ellis, N. Mittman, X. Xiaoqun Sun, M. Millward, G. Liu, S. Sun, M. R. Stockler, V. Cohen, N. Blais, R. Sangha, M. Boyer, R. Sasidharan, C. Lee, F. A. Shepherd, G. Goss, L. Seymour, N. B. Leighl
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review